-
US | INDIA +1-202-697-9162 | +91-124-429-4218
The global battery-free implants market was valued at $XX billion in 2016 and is forecast to exceed XX billion by 2023 at a Compound Annual Growth Rate (CAGR) of XX%. The market is principally determined by the aging population around the world. The aging population thusly increases the hospitalization rate, which increases the demand for implants. The overall increment in Gross Domestic Product (GDP) per capita prompts expanding healthcare expenditure, which thus drives the market growth. Increasing investment in healthcare infrastructure in developing economies by industries gives noteworthy open door for the future development of the battery-free implants market. It was obvious from the beginning that if an electrical device was to be fitted inside our heart there would be some complications: Battery failure, over-sensing (this occurs when pacer faces difficulty in differentiating electrical activity and stops correct pacing), under sensing, pacemaker syndrome, contamination of pacer through the skin, lead dislodgement. The problems are not limited to only pacemakers and hearts, but these also imply other life-saving devices like defibrillators and dialysis. Every few years or so patients must go under surgery for replacement of battery and leads. Scientist and researchers have come up with methods that would charge the batteries by making them ‘self-powered’ i.e. charging the implants by using body motion, metabolites, body heat, body fluids etc.
Alternatives that can act as a power source:
These innovations may lead to battery-free implantable device irreplaceable and offer a convincing development to battery-free implants technology for patients in future.
Deliverable Outlook:
Key questions answered in the report
1. Project Overview
2. Executive Summary
3. Battery Free Implants: Technology Overview
3.1 Approaches to Re-energize Implantable Medical Device
3.1.1 Harvesting Energy from Patient Body
3.1.1.1 Motion of patient coupled with Piezoelectric Generators
3.1.1.2 Biological Fluids
3.1.1.3 Metabolites
3.1.1.4 Thermoelectric Generators Utilizes Patient’s Body Heat as Power Source
3.1.2 External Unit to Continuously Power the Battery-Less Implant
3.1.2.1 Wireless Power Charging
3.1.2.1.1 Optical Charging
3.1.2.1.2 Inductive Coupling
3.1.2.1.3 Resonant Inductive Coupling
4. Technological Insights Upfront: Battery Free Implants
4.1 Wireless Powered Implants
4.1.1 Technology Segmentation
4.1.1.1 Wireless Power Transfer Technologies
4.1.1.1.1 Near-field technologies
4.1.1.1.2 Far-field technologies
4.1.1.2 Implant applications
4.1.1.2.1 Pacemakers
4.1.1.2.2 Defibrillators
4.1.1.2.3 Cochlear Implants
4.1.1.2.4 Artificial Pumps for Pumping Insulin or Other Substances
4.1.1.2.4 Other Medical Implants
4.1.2 Leading Wireless Charging Standard Associations
4.1.2.1 Wireless Power Consortium
4.1.2.2 Alliance for Wireless Power
4.1.3 Ranking of key technology companies/universities
4.1.3.1 Technology Innovations
4.1.3.2 Implant Applications
4.1.4 License Agreements and Partnerships
4.1.5 Mapping of Global Patenting Activity
4.1.6 Countries of Granted/Pending Patents for Main R&D Labs
4.1.7 IP Portfolio Size of Key Companies
4.1.8 IP Strength Index for Each Technology Segment
4.1.9 IP Blocking Potential
4.1.10 Market position vs IP position
4.1.11 IP portfolio summary for Wireless Power Transfer
4.1.11.1 Key Players
4.1.11.1.1 Thoratec
4.1.11.1.2 Univ Tufts
4.1.11.1.3 Otokinetics
4.1.11.1.4 Verily Life Sciences
4.1.11.1.5 Heartware
4.1.11.1.6 Samsung
4.1.11.2 Recent Patent Families of the Key Players Related to Wireless Power Transfer
4.1.11.3 Patent Under Litigations of the Key Players
4.1.11.4 Recent Merger/Acquisitions and/or Collaborations of the Key Players
4.1.11.5 Press Releases/Investor Updates of the Key Players
4.2 Motion/Kinetic Energy Powered Implants
4.2.1 Energy Harvesting from Moving Organs to Power Medical Implants
4.2.1.1 Heart Rhythms
4.2.1.2 Pulsating Lungs
4.2.2 Apparatus for Generating Electrical Energy from Subject’s Body
4.2.1 Piezoelectric Device
4.2.3 License Agreements and Partnerships
4.2.4 Mapping of Global Patenting Activity
4.2.5 Countries of Granted/Pending Patents for Main R&D Labs
4.2.6 IP Portfolio Size of Key companies/Universities
4.2.7 IP Strength Index for Each Technology Segment
4.2.8 IP Blocking Potential
4.2.9 Market position vs IP position
4.2.10 IP portfolio summary for motion powered implants
4.2.10.1 Key Players
4.2.10.1.1 Sirius Implantable Systems
4.2.10.1.2 Ethicon
4.2.10.1.3 Microsemi Semiconductor
4.2.10.1.4 University of Connecticut
4.2.10.2 Recent Patent Families of the Key Players Related to motion powered implants
4.2.10.3 Patent Under Litigations of the Companies and University
4.2.10.4 Recent Merger/Acquisitions and/or Collaborations of the Company & University
4.2.10.5 Press Releases/Investor Updates of the Companies
4.3 Blood Sugar as Power House for Biological Fuel Cell
4.3.1 Glucose powered implantable device
4.3.1.1 Surfaces Coatings of implants
4.3.1.2 Catalysts to Trigger a Continuous Electrochemical Reaction
4.3.2 Research Institutes and Companies to Lookout
4.3.2.1 University of Freiburg
4.3.2.2 Fujikin Incorporated
4.3.2.3 Japan as represented by president of National Cardiovascular Center
4.3.2.4 National Tsing Hua University (NTHU)
4.3.2.5 Siemens AG
4.3.3 License Agreements and Partnerships
4.3.4 Mapping of Global Patenting Activity
4.3.5 Countries of Granted/Pending Patents for Main R&D Labs
4.3.6 IP Portfolio Size
4.3.7 IP Strength Index for Each Technology Segment
4.3.8 IP Blocking Potential
4.3.9 Market position vs IP position
4.3.10 Patent portfolio summary for Wireless Power Transfer
4.3.10.1 Recent Patent Families of the Key Players Related to Biological Fuel Cell
4.3.10.2 Patent Under Litigations of the Companies
4.3.10.3 Recent Merger/Acquisitions and/or Collaborations of the Companies
4.3.10.4 Press Releases/Investor Updates of the Companies and Universities
4.4 Body Heat Powered Implants
4.4.1 Trickle charge
4.4.2 Thermoelectric Generators
4.4.3 Companies and Universities to Look Out
4.4.3.1 Biophan Technologies
4.4.3.2 Cardiff University
4.4.3.3 Stichting IMEC Nederland
4.4.3.4 California Institute of Technology
4.4.3.5 License Agreements and Partnerships
4.4.3.6 Mapping of Global Patenting Activity
4.4.3.7 Countries of Granted/Pending Patents for Main R&D Labs
4.4.3.8 IP Portfolio Size
4.4.3.9 IP Strength Index for Each Technology Segment
4.4.3.10 IP Blocking Potential
4.4.4 Market position vs IP position
4.4.5 Patent portfolio summary for Wireless Power Transfer
4.4.5.1 Recent Patent Families of the Key Players Related to Body Heat Powered Implants
4.4.5.2 Patent Under Litigations of the Companies
4.4.5.3 Recent Merger/Acquisitions and/or Collaborations of the Companies
4.4.5.4 Press Releases/Investor Updates of the Companies and Universities
5. Competitive Assessment
5.1 Companies providing Wireless Powered Implants
5.1.1 Business Overview
5.1.2 Marketed Products
5.2 Companies providing Motion Powered Implants
5.2.1 Business Overview
5.2.2 Marketed Products
5.3 Companies providing Blood Sugar as Power House for Biological Fuel Cell
5.3.1 Business Overview
5.3.2 Marketed Products
5.4 Companies providing Body Heat Powered Implants
5.4.1 Business Overview
5.4.2 Marketed Products
6. Global Battery Free Implants Market: Market Characterization
6.1 Global Battery Free Implants Market, Revenue ($bn), 2008 – 2016
6.2 Global Battery Free Implants Market, Revenue ($bn), 2016 – 2023
6.3 Global Battery Free Implants Market, Key Company Shares (%)
6.4 Global Battery Free Implants Market: Key Trends
6.5 Global Battery Free Implants Market Dynamics
6.5.1 Market Drivers
6.5.2 Market Restraints
6.6 Global Battery Free Implants Market: Country Analysis and Forecasts
6.6.1 Forecast Revenue, by Country
7. Global Battery Free Implants Market: Product Pipeline Analysis
7.1 Battery Free Implants – Pipeline Products Summary
7.2 Profiles of Key Pipeline Products
7.3 List of Pipeline Products
8. Global Battery Free Implants Market: Consolidation Landscape
8.1 Battery Free Implants Market: Deals by Count and Deal Value
8.2 Key Deals: 2008 – 2018
8.2.1 Agreement between Biophan Technologies and NASA
9. Appendix
9.1 Definitions
9.1.1 Patient Monitoring Devices
9.2 Acronyms
9.3 Sources
9.4 Research Methodology
9.4.1 Secondary Research
9.4.2 Primary Research
9.4.3 Forecasts
9.5 Contact Us
9.6 Disclaimer
10. List of Tables
11. List of Figures